Journal of Physical Chemistry B, Vol.117, No.33, 9655-9661, 2013
Exploring Novel Modified Vitamin B-12 as a Drug Carrier: Forecast from Density Functional Theory Modeling
Three non-native derivatives of vitamin B-12 with imidazole, ethylenediamine, and pyrazine as cobalt(III) beta-ligands were characterized by applying the BP/def2-TZVP density functional method. The binding of all three ligands is thermodynamically favorable. It is proposed that their synthesis might be possible from aquacobalamin as a starting form of vitamin BID as has been done in the case of an imidazole derivative of B-12 (Hannibal et al. Inorg. Chem. 2007, 46, 3613-3618). Furthermore, the possibility of the formation of their conjugates with cisplatin is investigated. The proposed beta-ligands may serve as bridging ligands, binding to the platin ion as N-donors. In parallel, the calculations are done for the previously synthetized B-12-cisplatin adduct with CN- as a bridging ligand and are compared with available experimental data, allowing assessment of the applied computational protocol. A good agreement between the computed and experimental structural parameters is obtained. In each of the studied structures, the Co-beta-ligand bond is weaker than the Pt-beta-ligand bond.